Statement of Shareholders' Equity (Parenthetical)	12 Months Ended
Dec. 31, 2020 USD ($)
Statement of Stockholders' Equity [Abstract]
Cost of Issuance of Common Stock, Preferred Stock and Warrants for Clinical Trial Funding Commitment	$ 7,507,123
Fair value	$ 370,666

Cost of Issuance of Common Stock, Preferred Stock and Warrants for Clinical Trial Funding Commitment

No definition available.

Name:	trov_CostofIssuanceofCommonStockPreferredStockandWarrantsforClinicalTrialFundingCommitment
Namespace Prefix:	trov_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration